AB313: Bill Text

LRB-3362/2

KP:cjs

2019 - 2020 LEGISLATURE

2019 Assembly BILL 313

June 27, 2019 - Introduced by Representatives Mursau, Milroy, Anderson, Crowley, Edming, Gruszynski, Hesselbein, Kulp, B. Meyers, Ohnstad, Ott, Ramthun, Rodriguez, Sargent, Shankland, Sinicki, Snyder, Spreitzer, Tauchen, Thiesfeldt, Tusler and Rohrkaste, cosponsored by Senators Cowles, Miller, Hansen, Kapenga, Larson, Olsen, Petrowski, Ringhand, Smith and Tiffany. Referred to Committee on Health.

AB313,1,1 An Act relating to: establishing a tick-borne disease study committee.

Analysis by the Legislative Reference Bureau

This bill creates a Tick-borne Disease Study Committee consisting of the secretary of health services, the secretary of natural resources, the commissioner of insurance, and 13 members appointed by the governor. Under the bill, the Tick-borne Disease Study Committee studies issues involving awareness, prevention, surveillance, diagnosis, reporting, and treatment of Lyme disease and other tick-borne diseases and submits a report containing policy recommendations to the legislature within three years after the bill takes effect.

For further information see the state fiscal estimate, which will be printed as an appendix to this bill.

The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:

AB313,1 Section 1. Nonstatutory provisions.

AB313,1,3 (1) Tick-borne disease study committee.

AB313,1,5 (a) There is created a tick-borne disease study committee consisting of the following members:

AB313,1,6 1. The secretary of health services or the secretary's designee.

AB313,2,1 2. The secretary of natural resources or the secretary's designee.

AB313,2,2 3. The commissioner of insurance or the commissioner's designee.

AB313,2,5 4. Three health care providers, as defined in s. 146.81 (1), appointed by the governor. At least one of the members appointed under this subdivision shall reside north of USH 10.

AB313,2,7 5. Two educators knowledgeable about Lyme disease or another vector-borne disease, appointed by the governor.

AB313,2,9 6. One representative of the private health insurance industry based in this state, appointed by the governor.

AB313,2,11 7. One person employed in the administration of a hospital in this state, appointed by the governor.

AB313,2,14 8. Two members appointed by the governor who are advocates for Lyme disease policy or residents of this state affected by Lyme disease. At least one of the members appointed under this subdivision shall reside north of USH 10.

AB313,2,16 9. One representative of a nonprofit organization with a purpose involving outdoor recreation, appointed by the governor.

AB313,2,19 10. Two representatives of county health departments, appointed by the governor. At least one of the members appointed under this subdivision shall represent a county that is located at least in part north of USH 10.

AB313,2,21 11. One representative of an organization representing local health departments and boards, appointed by the governor.

AB313,3,3 (b) No later than 3 years after the effective date of this paragraph, the tick-borne disease study committee shall submit a report to the legislature in the manner provided under s. 13.172 (2). In preparing the report, the committee shall study issues involving awareness, prevention, surveillance, diagnosis, reporting, and treatment of Lyme disease and other tick-borne diseases. The report shall include all of the following recommendations approved by a majority of the committee:

AB313,3,6 1. Recommendations for policies addressing awareness, prevention, surveillance, diagnosis, reporting, and treatment of Lyme disease and other tick-borne diseases.

AB313,3,8 2. Recommendations for the long-term use of antibiotics in the treatment of tick-borne diseases and insurance coverage of long-term use of antibiotics.

AB313,3,10 3. Recommendations for policies about notifying people about the increased potential of receiving a false negative test in the early stages of a tick-borne disease.

AB313,3,12 (c) The tick-borne disease study committee terminates upon submission of the report under par. (b).

AB313,2 Section 2. Effective date.

AB313,3,15 (1) This act takes effect on first day of the 7th month beginning after publication.

AB313,3,16 (End)